Figures for the coronavirus outbreak in China totalled 80,754 as of 9 March 2020. According to the National Health Commission there were 3,136 reported fatalities with 59,897 recovered cases. The Chinese mainland reported 19 new cases of confirmed infections, 36 new cases of suspected infections, and 17 deaths (all in Hubei province).

In response to the virus, the Chinese government has pushed for more counter-cyclical efforts as well as the implementation of expansionary fiscal and expansionary monetary policy. Under the quarantine and back-to-work policies, President Xi highlighted the importance of implementing epidemic control measures while also resuming production in areas classified as low risk. Multiple cities have revealed policies that will help subsidise home purchases. The National Development and Reform Commission (NDRC) temporarily cut unit prices of electricity as well as natural gas. Largely, efforts to control the outbreak in Wuhan and Hubei include setting up 42 designated hospitals, 21,574 beds to treat patients, 10,317 additional beds in shelters to handle patients showing milder symptoms and 27,387 medical staff who have come in across the country to provide support. (These figures are as at 20 February 2020 and sourced from Bloomberg, the WHO and Chinese press reports).

Economic disruption persists

Although provinces in China have resumed business activities, the country still faces a shortage of workers in the movement of goods. Activity levels remain at 20-30% of 2019 historic levels. Provinces such as Guangdong (a hub for electronics) and Hebei (a hub for metallurgy) have resumed manufacturing activities faster than other municipalities.

Various sectors are being impacted. This includes tourism & hospitality, aviation/airlines, luxury goods, automotive sector, consumer products as well as consumer electronics & semi-conductors domestically.

Investment strategy - we're still bullish on Asia

Medium-term, we continue to remain positive on Asian markets and are confident that growth should recover after Q1, 2020. With inventory levels low globally, we may see a strong order momentum in the coming months to replenish stock.

In China, we believe things should improve considerably post Q1, 2020. We maintain our views and do not seek to change our positions. Overall, we are seeing 70% of scheduled flights down and jet fuel demand for February drop to 77% year-on-year. We believe the turning point for tourism will be when the WHO lifts its global alert on the virus, similar to SARS. Further, the vast majority of companies within our portfolio that are in online entertainment, education, food delivery and finance sectors have fairly robust digital interfaces. These companies should see a market share shift from their pure brick and mortar peers.

In India there are not many virus cases being reported, providing some level of comfort. The economic recovery may be delayed from negative sentiment globally but will still be underway nevertheless. Our medium-term view on India is still positive. With a forecast recovery in place, we're positioning ourselves with an overweight exposure in financials, real estate, consumer discretionary and healthcare sectors. We are expecting rural demand recovery and with increased compliance post-GST, which should lead to higher growth for organised sectors. 

Deep value exists in some of state-owned enterprises in the energy & utility space. Should the Modi Government pursue the much-articulated path of privatisation of these assets, meaningful upside can be realised over the next 12-18 months. The spread of the coronavirus, along with the trade war & tax cuts, may hasten the diversification of supply chains away from China to India, a positive from a medium-term perspective.

Outside Asia, global markets are sanguine on the back of improving PMIs, a function of inventory restocking demand and expanding Central Bank balance sheets. For Asian equities, as investors get confidence the coronavirus situation is not significantly deteriorating, markets should bottom.

Overall, the impact of the virus will affect performance in the short-term. To put it into perspective, a quarter of negative sentiment and growth is priced in post a 5-7% market correction, but will not have a material impact on long-term portfolio holdings.

3 stock stories

Much of the fundamentals leading to our conviction in the securities we invest in remain largely unchanged. Here are three I'd like to share.

• TAL Education (NYSE:TAL) is an education provider in China we have been invested in for some time. Due to the impact of coronavirus and temporary suspension of the company’s offline business as precautionary measures to contain infections, the company produced weaker than expected results over the recent quarter. TAL, however, continued to perform positively through the outbreak by partially offsetting its revenues via an increase of student enrollments in its online courses.
• A company we like that is not well known to many outside of India is Dabur (NSE:DABUR). A leading home-grown fast-moving consumer goods company specialising in Ayurveda health and personal care; the company captures much of local consumers' changing preferences toward natural Ayurvedic products. Dabur leads in innovation, focusing on the premium segment and millennial customers.
• Across ASEAN, while Vietnam has suffered from Chinese tourist travel restrictions, domestically it continues to demonstrate strong fundamentals. In this regard, Vietnam Technological & Commercial Joint Stock Bank stands out as a positive contributor in our fund overall.

Invest in sector leading companies

Mirae Asset focuses on identifying ‘Sector Leaders’ that will benefit from competitive advantages and deliver sustainable growth over the long-term. Click the 'FOLLOW' button below for more insights